JPWO2021046445A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021046445A5
JPWO2021046445A5 JP2022514522A JP2022514522A JPWO2021046445A5 JP WO2021046445 A5 JPWO2021046445 A5 JP WO2021046445A5 JP 2022514522 A JP2022514522 A JP 2022514522A JP 2022514522 A JP2022514522 A JP 2022514522A JP WO2021046445 A5 JPWO2021046445 A5 JP WO2021046445A5
Authority
JP
Japan
Prior art keywords
nucleic acid
item
cells
seq
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022514522A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022546577A5 (https=
JP2022546577A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/049538 external-priority patent/WO2021046445A1/en
Publication of JP2022546577A publication Critical patent/JP2022546577A/ja
Publication of JP2022546577A5 publication Critical patent/JP2022546577A5/ja
Publication of JPWO2021046445A5 publication Critical patent/JPWO2021046445A5/ja
Pending legal-status Critical Current

Links

JP2022514522A 2019-09-05 2020-09-04 Ｂｃｍａと結合する二量体抗原受容体（ｄａｒ） Pending JP2022546577A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201962896190P 2019-09-05 2019-09-05
US62/896,190 2019-09-05
US201962896990P 2019-09-06 2019-09-06
US62/896,990 2019-09-06
US201962910341P 2019-10-03 2019-10-03
US62/910,341 2019-10-03
US201962943069P 2019-12-03 2019-12-03
US62/943,069 2019-12-03
US202063030145P 2020-05-26 2020-05-26
US63/030,145 2020-05-26
PCT/US2020/049538 WO2021046445A1 (en) 2019-09-05 2020-09-04 Dimeric antigen receptors (dar) that bind bcma

Publications (3)

Publication Number Publication Date
JP2022546577A JP2022546577A (ja) 2022-11-04
JP2022546577A5 JP2022546577A5 (https=) 2023-09-11
JPWO2021046445A5 true JPWO2021046445A5 (https=) 2023-09-11

Family

ID=74852154

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022514522A Pending JP2022546577A (ja) 2019-09-05 2020-09-04 Ｂｃｍａと結合する二量体抗原受容体（ｄａｒ）

Country Status (10)

Country Link
US (1) US20220251168A1 (https=)
EP (1) EP4025227A4 (https=)
JP (1) JP2022546577A (https=)
KR (1) KR20220057598A (https=)
CN (1) CN114650829A (https=)
AU (1) AU2020341712A1 (https=)
CA (1) CA3149867A1 (https=)
IL (1) IL291076A (https=)
MX (1) MX2022002723A (https=)
WO (1) WO2021046445A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202109163YA (en) * 2019-02-26 2021-09-29 Sorrento Therapeutics Inc Antigen binding proteins that bind bcma
EP4139345A1 (en) 2020-04-24 2023-03-01 Sorrento Therapeutics, Inc. Memory dimeric antigen receptors
WO2022226364A2 (en) * 2021-04-23 2022-10-27 Sorrento Therapeutics, Inc. Dimeric antigen receptors (dars) that bind gd2
KR20240051280A (ko) * 2021-09-06 2024-04-19 젠맵 에이/에스 Cd27과 결합할 수 있는 항체, 그의 변이체 및 그의 용도
CN116655805B (zh) * 2023-05-31 2024-03-08 四川大学华西医院 一种靶向her2阳性肿瘤的新型car-t细胞及制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015166056A1 (en) * 2014-05-02 2015-11-05 Cellectis Cs1 specific multi-chain chimeric antigen receptor
PT3294764T (pt) 2015-05-15 2021-02-15 Hope City Composições de recetores de antigénios quiméricos
US11173179B2 (en) * 2015-06-25 2021-11-16 Icell Gene Therapeutics Llc Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof
EP3842450A1 (en) * 2015-10-23 2021-06-30 Eureka Therapeutics, Inc. Antibody/t-cell receptor chimeric constructs and uses thereof
US12195529B2 (en) * 2017-06-21 2025-01-14 Gsbio, Llc Heterodimeric bispecific antibodies
AU2018358067A1 (en) * 2017-11-01 2020-05-07 Juno Therapeutics, Inc. Antibodies and chimeric antigen receptors specific for B-cell maturation antigen
SG11202008568WA (en) * 2018-03-09 2020-10-29 Sorrento Therapeutics Inc Dimeric antigen receptors (dar)
SG11202109163YA (en) * 2019-02-26 2021-09-29 Sorrento Therapeutics Inc Antigen binding proteins that bind bcma

Similar Documents

Publication Publication Date Title
Azuma Co-signal molecules in T-cell activation: historical overview and perspective
US12059436B2 (en) BCMA-CAR-T cells
US5686281A (en) Chimeric receptor molecules for delivery of co-stimulatory signals
US11760806B2 (en) CD-38 directed chimeric antigen receptor constructs
KR20210107058A (ko) 인간 pd-1에 대항하는 이작용성 분자
JP2020511529A5 (https=)
JP2018535701A5 (https=)
KR20210107062A (ko) 이작용성 항-PD-1/SIRPα 분자
JP2006518984A (ja) キメラ細胞質シグナル伝達分子
CA3132202A1 (en) Humanized anti-dll3 chimeric antigen receptors and uses thereof
JP2021520780A (ja) Ｎｋｇ２ｄキメラ抗原受容体
KR20240005741A (ko) 특성이 향상된 이작용성 분자용 신규한 스캐폴드
EP4196231A1 (en) Chimeric antigen receptor t cells for treating autoimmunity
JPWO2021046445A5 (https=)
US20240261330A1 (en) CD19-Directed Chimeric Antigen Receptor Constructs
KR20220114637A (ko) Il-7 변이체를 포함하는 이작용성 분자
CN120789243A (zh) 用于治疗髓系恶性肿瘤的嵌合抗原受体
JPWO2023274384A5 (https=)
US20240173411A1 (en) Methods for treating cd83-expressing cancer
JPWO2023030272A5 (https=)
WO2025081163A1 (en) Compositions for the treatment of cancer
CN120529915A (zh) 嵌合抗原受体和抗体-nkg2d配体结构域融合蛋白
JPWO2021174124A5 (https=)
WO2025120560A1 (en) Targeting modules against cd19 and cd20 for use in a method for stimulating a reversed
EP4731753A2 (en) Gpc3-targeted molecules and uses thereof